knowledge -WSS

knowledge

author：comprehensive 2025-10-02 21:36:45 - browse：91497

A glass office building of MassMutual with its sign on the top left — insurance coverage from STAT — Adobe

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.

MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer. The Springfield, Mass.-based insurer hopes that when people learn they carry a genetic predisposition, they’ll take action to lower their risk through diet, exercise, and getting regular screenings.

Viewed one way, it’s a win-win: The longer its members live, the longer MassMutual can collect and invest their premiums without paying out.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Christmas in the PICU brings some surprising joy

WSS

A pediatrician calls for Congress to pass the child tax credit deal

How to keep neuroscience’s past racism from being its future

CVS is on a mission to consolidate health care. Will it work?

Albert Bourla of Pfizer: worst biopharma CEO of 2023

HCA sued by state AG for quality issues at Mission Health

Head of FDA's diagnostics center, who led through Covid, retires

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Editas, Vertex strike deal on CRISPR

After affirmative action ruling, medical educators look to 'holistic review'

Violet CEO on training clinicians to promote more inclusive care

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Flu vaccine reformulation won't be easy, manufacturers warn

Activists slam private health insurers over coverage restrictions

Maisha Meds is a PBM, but don't call it that

Supreme Court strikes down use of affirmative action

Immunocompromised patients offer clues on chronic Covid

explore

Microsoft launches AI tool for clinical documentation through Epic

Violet CEO on training clinicians to promote more inclusive care

Mass General, Mayo Clinic look to monetize custom

Prior authorization reform is both possible and imperative

Editas, Vertex strike deal on CRISPR

Christmas in the PICU brings some surprising joy

focus

Wikipedia

hotspot

focus